Detalhe da pesquisa
1.
Alterations in plasma triglycerides and ceramides: links with cardiac function in humans with type 2 diabetes.
J Lipid Res
; 61(7): 1065-1074, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32393551
2.
Beliefs, risk perceptions, and lipid management among patients with and without diabetes: Results from the PALM registry.
Am Heart J
; 225: 88-96, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32485329
3.
Practice-level variation in statin use and low-density lipoprotein cholesterol control in the United States: Results from the Patient and Provider Assessment of Lipid Management (PALM) registry.
Am Heart J
; 214: 113-124, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31202098
4.
Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease: The CLEAR Wisdom Randomized Clinical Trial.
JAMA
; 322(18): 1780-1788, 2019 11 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31714986
5.
Lipid management in contemporary community practice: Results from the Provider Assessment of Lipid Management (PALM) Registry.
Am Heart J
; 193: 84-92, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29129260
6.
Antidrug Antibodies in Patients Treated with Alirocumab.
N Engl J Med
; 376(16): 1589-90, 2017 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28304229
7.
Design and rationale for the Patient and Provider Assessment of Lipid Management (PALM) registry.
Am Heart J
; 170(5): 865-71, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26542493
8.
Efficacy and safety of bempedoic acid in patients with heterozygous familial hypercholesterolemia: analysis of pooled patient-level data from phase 3 clinical trials.
J Clin Lipidol
; 18(2): e153-e165, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38341323
9.
Identification of people with heterozygous familial hypercholesterolemia.
Curr Opin Lipidol
; 23(4): 282-9, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22801386
10.
Evaluation of the efficacy and safety of bempedoic acid in women and men: Pooled analyses from phase 3 trials.
Atherosclerosis
; 384: 117192, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37648637
11.
Sex-related differences in premature cardiovascular disease in familial hypercholesterolemia.
J Clin Lipidol
; 17(1): 150-156, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36470719
12.
Designing implementation strategies to improve identification, cascade testing, and management of families with familial hypercholesterolemia: An intervention mapping approach.
Front Health Serv
; 3: 1104311, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37188259
13.
Knowing the Prevalence of Familial Hypercholesterolemia Matters.
Circulation
; 133(11): 1054-7, 2016 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26976913
14.
Efficacy and safety of bempedoic acid in patients not receiving statins in phase 3 clinical trials.
J Clin Lipidol
; 16(3): 286-297, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35346603
15.
Transcatheter aortic valve replacement in a patient with premature coronary artery disease and calcific aortic stenosis complicated by heterozygous familial hypercholesterolemia.
J Clin Lipidol
; 15(6): 793-795, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34645588
16.
JCL Roundtable. Making prevention a priority.
J Clin Lipidol
; 15(4): 530-537, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34815066
17.
Bempedoic Acid for Heterozygous Familial Hypercholesterolemia: From Bench to Bedside.
Drug Des Devel Ther
; 15: 1955-1963, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34007155
18.
Racial Disparities in Modifiable Risk Factors and Statin Usage in Black Patients With Familial Hypercholesterolemia.
J Am Heart Assoc
; 10(17): e020890, 2021 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34431361
19.
Patient perceptions and use of non-statin lipid lowering therapy among patients with or at risk for atherosclerotic cardiovascular disease: Insights from the PALM registry.
Clin Cardiol
; 44(6): 863-870, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34008247
20.
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
Circulation
; 129(25 Suppl 2): S1-45, 2014 Jun 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-24222016